Sakthivel P - Search Results

1

Therapeutic intervention in cancer and chronic viral infections: antibody mediated manipulation of PD-1/PD-L1 interaction.

Sakthivel P, Gereke M, Bruder D. Sakthivel P, et al. Rev Recent Clin Trials. 2012 Feb;7(1):10-23. doi: 10.2174/157488712799363262. Rev Recent Clin Trials. 2012. PMID: 22023178 Review.

2

Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells.

Sakthivel P, Gereke M, Breithaupt A, Fuchs D, Gigliotti L, Gruber AD, Dianzani U, Bruder D. Sakthivel P, et al. PLoS One. 2014 Jul 16;9(7):e100970. doi: 10.1371/journal.pone.0100970. eCollection 2014. PLoS One. 2014. PMID: 25029240 Free PMC article.

3

Mechanism of granuloma formation in sarcoidosis.

Sakthivel P, Bruder D. Sakthivel P, et al. Curr Opin Hematol. 2017 Jan;24(1):59-65. doi: 10.1097/MOH.0000000000000301. Curr Opin Hematol. 2017. PMID: 27755127 Review.

4

Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.

Sakthivel P, Grunewald J, Eklund A, Bruder D, Wahlström J. Sakthivel P, et al. Clin Exp Immunol. 2016 Feb;183(2):294-306. doi: 10.1111/cei.12715. Epub 2015 Nov 24. Clin Exp Immunol. 2016. PMID: 26415669 Free PMC article.

5

Abscisic Acid: A Phytohormone and Mammalian Cytokine as Novel Pharmacon with Potential for Future Development into Clinical Applications.

Sakthivel P, Sharma N, Klahn P, Gereke M, Bruder D. Sakthivel P, et al. Curr Med Chem. 2016;23(15):1549-70. doi: 10.2174/0929867323666160405113129. Curr Med Chem. 2016. PMID: 27048335 Review.

6

Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.

Sakthivel P, Breithaupt A, Gereke M, Copland DA, Schulz C, Gruber AD, Dick AD, Schreiber J, Bruder D. Sakthivel P, et al. Lung. 2017 Feb;195(1):59-68. doi: 10.1007/s00408-016-9962-4. Epub 2016 Nov 18. Lung. 2017. PMID: 27864635

7

Intranasal formulations: promising strategy to deliver vaccines.

Riese P, Sakthivel P, Trittel S, Guzmán CA. Riese P, et al. Among authors: sakthivel p. Expert Opin Drug Deliv. 2014 Oct;11(10):1619-34. doi: 10.1517/17425247.2014.931936. Epub 2014 Jun 25. Expert Opin Drug Deliv. 2014. PMID: 24962722 Review.

8

Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population.

Sakthivel P, Wermeling F, Elmgren A, Hulthe J, Kakoulidou M, Lefvert AK, Lind L. Sakthivel P, et al. Scand J Clin Lab Invest. 2010 Jul;70(4):237-43. doi: 10.3109/00365511003695608. Scand J Clin Lab Invest. 2010. PMID: 20331384

9

Programmed Death-1: from gene to protein in autoimmune human myasthenia gravis.

Sakthivel P, Ramanujam R, Wang XB, Pirskanen R, Lefvert AK. Sakthivel P, et al. J Neuroimmunol. 2008 Jan;193(1-2):149-55. doi: 10.1016/j.jneuroim.2007.09.019. Epub 2007 Nov 26. J Neuroimmunol. 2008. PMID: 18037500

10

Bench to bedside of CTLA-4: a novel immuno-therapeutic agent for inflammatory disorders.

Sakthivel P. Sakthivel P. Recent Pat Inflamm Allergy Drug Discov. 2009 Jun;3(2):84-95. doi: 10.2174/187221309788489805. Recent Pat Inflamm Allergy Drug Discov. 2009. PMID: 19519585 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page